Both the Pfizer and AstraZeneca covid-19 vaccines produced a strong immune response in people aged over 80 right from their first dose. Preliminary Study suggested that over 93 percent of people had produced COVID-19 antibodies after receiving the Pfizer vaccine and 87 percent of people after receiving the AstraZeneca jab. This was the first study that took place in order to compare the performance of the two vaccines.

People who received the AstraZeneca vaccine have displayed a greater T-cell response, which is responsible to form another important arm of the body’s immune response to the viruses. Only 12 percent of people who had the Pfizer vaccine developed T-cells against the coronavirus spike protein compared with 31 percent of those who had received the AstraZeneca dose.

Overall immune responses were found to be much higher in people who had covid-19 infections in the past, compared with those who hadn’t. This preliminary study was completed by Helen Parry at the University of Birmingham, UK, and the individuals who broke down insusceptible reactions in a gathering of 165 volunteers matured 80 and over, every one of whom had gotten a solitary portion of either the Pfizer or AstraZeneca vaccine five to about a month and a half prior.